Innate Pharma SA(FR:IPH)
€1.33-0.06 (-4.33%)
FR:IPH
Innate Pharma SA earnings date
€1.33
At close:-0.06 (-4.33%)
Want to see FR:IPH full AI Analyst Report?
Innate Pharma SA (IPH) Q1 2019 Earnings Report
10 Followers
FR:IPH Q1 2019 EPS Results
- Actual EPS
- EUR 0.31
- Consensus EPS
- EUR 0.22
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- -EUR 0.43
FR:IPH Q1 2019 Revenue Results
- Actual Revenue
- EUR 63.01M
- Expected Revenue
- EUR 43.21M
- Beat/Miss
- Beat by +EUR 19.81M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q1 2019
- Date
- 05/15/2019
- Time
- Before Open
- Conference Call
- Wednesday, May 15, 2019
FR:IPH Upcoming Earnings
Innate Pharma SA's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q1 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
FR:IPH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.10- | -0.31 | ― | ― |
| Sep 17, 2026 | 2026 (Q2) | -0.16-0.21 | -0.25 | 16.00% (+0.04) | |
| Mar 26, 2026 | 2025 (Q4) | -0.12-0.31 | -0.31 | 0.00% (+0.00) | |
| Sep 17, 2025 | 2025 (Q2) | -0.28-0.25 | -0.31 | 19.35% (+0.06) | |
| Mar 27, 2025 | 2024 (Q4) | -0.26-0.31 | -0.12 | -158.33% (-0.19) | |
| Sep 12, 2024 | 2024 (Q2) | -0.28-0.31 | 0.02 | -1650.00% (-0.33) | |
| Mar 21, 2024 | 2023 (Q4) | -0.40-0.12 | -0.81 | 85.19% (+0.69) | |
| Sep 14, 2023 | 2023 (Q2) | 0.080.02 | 0.08 | -75.00% (-0.06) | |
| Mar 23, 2023 | 2022 (Q4) | -0.39-0.81 | -0.35 | -131.43% (-0.46) | |
| Sep 15, 2022 | 2022 (Q2) | 0.330.08 | -0.3 | 126.67% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
